Patient Leaflet Updated 04-Aug-2025 | Ferring Pharmaceuticals Ltd
Tractocile 7.5 mg/ml Solution for Injection
Tractocile®
6.75 mg/0.9 ml solution for injection
Atosiban
1. What Tractocile is and what it is used for
2. What you need to know before you are given Tractocile
3. How Tractocile will be given
4. Possible side effects
5. How to store Tractocile
6. Contents of the pack and other information
Tractocile contains atosiban. Tractocile can be used to delay the premature birth of your baby. Tractocile is used in pregnant adult women, from week 24 to week 33 of the pregnancy.
Tractocile works by making the contractions in your womb (uterus) less strong. It also makes the contractions happen less often. It does this by blocking the effect of a natural hormone in your body called “oxytocin” which causes your womb (uterus) to contract.
Do not use Tractocile if any of the above apply to you. If you are not sure, talk to your doctor, midwife or pharmacist before you are given Tractocile.
Talk to your doctor, midwife or pharmacist before you are given Tractocile:
If any of the above apply to you (or you are not sure), talk to your doctor, midwife or pharmacist before you are given Tractocile.
Tractocile has not been studied in pregnant women less than 18 years old.
Tell your doctor, midwife or pharmacist if you are taking, have recently taken or might take any other medicines.
If you are pregnant and breast-feeding an earlier child, you should stop breast-feeding while you are given Tractocile.
Tractocile will be given to you in a hospital by a doctor, nurse or midwife. They will decide how much you need. They will also make sure the solution is clear and free from particles.
Tractocile will be given into a vein (intravenously) in three stages:
Treatment should last no longer than 48 hours in total.
Further treatment with Tractocile can be used if your contractions start again. Treatment with Tractocile can be repeated up to three more times.
During treatment with Tractocile, your contractions and your unborn baby’s heart rate may be monitored.
It is recommended that no more than three re-treatments should be used during a pregnancy.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The side effects seen in the mother are generally of a mild severity. There are no known side effects on the unborn or new-born baby.
The following side effects may happen with this medicine:
Very common (affects more than 1 in 10 people)
Common (affects less than 1 in 10 people)
Uncommon (affects less than 1 in 100 people)
Rare (affects less than 1 in 1,000 people)
You may experience shortness of breath or lung oedema (accumulation of fluid in the lungs), particularly if you are pregnant with more than one baby and/or are given medicines that can delay the birth of your baby, such as medicines used for high blood pressure.
If you get any side effects, talk to your doctor, midwife or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see below). By reporting side effects you can help provide more information on the safety of this medicine.
United Kingdom
Ireland
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.
Store in a refrigerator (2°C - 8°C).
Store in the original package in order to protect from light.
Once the vial has been opened, the product must be used straight away.
Do not use this medicine if you notice particulate matter and discoloration prior to administration.
Tractocile 6.75 mg/0.9 ml solution for injection is a clear, colourless solution without particles. One pack contains one vial containing 0.9 ml solution.
EU/1/99/124/001
PLGB 03194/0137
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
This leaflet was last revised in April 2022.
Detailed information on this medicine is available on the European Medicines Agency web site:
http://www.ema.europa.eu.
Tractocile, FERRING and the FERRING Logo are trademarks of Ferring B.V.© 2022 Ferring B.V.
5009000995
Drayton Hall, Church Road, West Drayton, UB7 7PS, UK
+44 (0)844 931 0051
http://www.ferring.co.uk
+44 (0)844 931 0050
0800 111 4125